Monthly Subscription
Unlimited document downloads
$99


Custom Document Search
Locate hard-to-find documents, quickly and inexpensively
$59

See also:

company_intel Nastech Pharmaceutical Co. Inc.


The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$47
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Agreement Nastech Pharmaceutical Co. Inc. Schwarz Pharma, Inc.
$36
 Subscribers Subscribers
Preview 		2005
 ContractIntelligence Agreement of Lease Nastech Pharmaceutical Co. Inc.
$41
 Subscribers Subscribers
2004
 For Immediate Release Chronimed Inc. Nastech Pharmaceutical Co. Inc.
$32
 Subscribers Subscribers
Preview 		2004
 For Immediate Release Nastech Pharmaceutical Co. Inc. Questcor Pharmaceuticals Inc.
$43
 Subscribers Subscribers
Preview 		2004
 For Immediate Release Nastech Pharmaceutical Co. Inc.
$35
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Nastech Pharmaceutical Co. Inc.
$36
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Nastech;
Schering 		BankLehman Brothers
$39
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Nastech Pharmaceutical Co. Inc. BankLehman Brothers Inc.
$40
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Alkermes;
Genentech;
Nastech 		Questcor Pharma;
M.I.T.;
North Carolina
$35
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Nastech Pharmaceutical Co. Inc.
$36
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Aventis Pharma;
Nastech 		Questcor Pharma
$35
 Subscribers Subscribers
Preview 		2002
 For Immediate Release Cardinal Health, Inc. Nastech Pharmaceutical Co. Inc.
$38
 Subscribers Subscribers
Preview 		2002
 For Immediate Release Nastech Pharmaceutical Co. Inc. Pharmacia Corp.
$34
 Subscribers Subscribers
Preview 		2000
 For Immediate Release Nastech;
Schwarz Pharma;
Sonus Pharma 		M.I.T.;
Stanford;
Michigan
$38
 Subscribers Subscribers
Preview 		2000
 For Immediate Release Nastech Pharmaceutical Co. Inc.
$40
 Subscribers Subscribers
Preview 		2003
 Nastech Pharmaceutical Company Inc. Reports Solid First Quarter 2003 Financial Results Nastech Pharmaceutical Co. Inc. Pfizer, Inc.
$33
 Subscribers Subscribers
Preview 		2003
 Pharmacia Corporation Reports 11% Increase in Earnings per Share (EPS) for Fourth Quarter of 2002 Allergan;
Celltech Group;
Nastech 		Pfizer;
Pharmacia